News search

Cutting-edge research and insightful commentary from world-leading experts.

81 results were found based on your search term

Drug to delay Type 1 Diabetes approved for UK use
NICE approves Teplizumab which was used under early access scheme for first time in UK in Birmingham
- Published: 23 June 2026
Birmingham researchers receive funding to improve patients’ lives during and after cancer treatment
Three University of Birmingham researchers will investigate why cancer immunotherapy can cause harmful side effects and how to predict, prevent and treat them.
- Published: 8 June 2026
Spotlight on BactiVac Network training opportunities
Uzal shares his story of resilience, which features a successful training opportunity in the UK, awarded and funded by the BactiVac Network.
- Published: 13 May 2026
Funding boost for bacterial vaccine research to improve global outbreak preparedness
Birmingham lead on vaccine research for bacterial pathogens with focus on those pathogens of significant public health importance in low resource settings.
- Published: 7 May 2026
US-UK nanotech partners speed push for equitable diagnostics
Birmingham-Illinois team drives new generation of ultra sensitive, affordable diagnostic technologies to reduce global health inequalities.
- Published: 21 April 2026
Immunology expert answers Meningitis questions
Dr Rebecca Drummond writes for The Conversation about meningitis infections, how it spreads and who is most at risk
- Published: 19 March 2026
Personalised mRNA vaccine trials in pancreatic cancer
Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.
- Published: 13 March 2026
Mpox immune test validated during Rwandan outbreak
Serum and dried blood spot test able to identify those with infection and vaccine-derived antibodies – helping authorities to prioritise vaccine use
- Published: 9 March 2026